Valuation: Amgen Inc.

Market Cap 202B 177B 162B 151B 287B 19,227B 291B 1,948B 757B 9,451B 758B 742B 32,567B P/E 2026 *
24.5x
P/E 2027 * 22.4x
Enterprise Value 244B 213B 196B 182B 346B 23,201B 351B 2,350B 914B 11,404B 915B 895B 39,299B EV / Sales 2026 *
6.45x
EV / Sales 2027 * 6.15x
Free-Float
99.78%
Yield 2026 *
2.7%
Yield 2027 * 2.85%
1 day-0.28%
1 week+4.41%
Current month+3.32%
1 month+7.03%
3 months+7.53%
6 months+16.66%
Current year+14.31%
1 week 356.87
Extreme 356.87
375.15
1 month 334.05
Extreme 334.0501
375.15
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 218.44
Extreme 218.44
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+3.55%+4.41%+25.45%+65.64% 202B
+1.86%+0.48%+55.50%+160.66% 1,082B
+3.57%+3.29%+68.60%+61.56% 633B
+3.99%+3.05%+37.93%+89.70% 461B
-1.29%+1.37%+31.00%+23.05% 338B
-1.45%-0.49%+39.24%+37.76% 299B
-0.38%+0.89%+30.44%+45.23% 291B
-0.89%+2.62%-26.76%-40.28% 222B
+4.21%+2.65%+17.47%+69.95% 163B
+1.84%+0.12%-4.18%-33.30% 139B
Average -0.64%+4.28%+27.47%+48.00% 383.1B
Weighted average by Cap. -0.73%+5.33%+40.09%+77.70%

Financials

2026 *2027 *
Net sales 37.77B 33.02B 30.34B 28.28B 53.64B 3,596B 54.45B 364B 142B 1,768B 142B 139B 6,091B 38.72B 33.85B 31.11B 29B 55B 3,687B 55.83B 373B 145B 1,812B 145B 142B 6,245B
Net income 8.23B 7.2B 6.61B 6.16B 11.69B 784B 11.87B 79.39B 30.86B 385B 30.9B 30.23B 1,328B 8.86B 7.75B 7.12B 6.64B 12.59B 844B 12.78B 85.5B 33.24B 415B 33.27B 32.56B 1,430B
Net Debt 41.74B 36.49B 33.53B 31.26B 59.28B 3,974B 60.18B 403B 156B 1,954B 157B 153B 6,732B 36.13B 31.58B 29.02B 27.05B 51.31B 3,440B 52.09B 348B 135B 1,691B 136B 133B 5,826B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-07-02 $374.15 +3.55% 2,487,837
26-07-01 $361.33 -0.22% 2,244,791
26-06-30 $362.12 +0.44% 2,246,908
26-06-29 $360.55 +0.62% 2,461,887
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
374.15USD
Average target price
354.76USD
Spread / Average Target
-5.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock